A5066023919- Atomic and Molecular Physics
- Cancer Immunotherapy and Biomarkers
- Endometrial and Cervical Cancer Treatments
- X-ray Spectroscopy and Fluorescence Analysis
- Particle accelerators and beam dynamics
- Genetic factors in colorectal cancer
- thermodynamics and calorimetric analyses
- Mass Spectrometry Techniques and Applications
- Carbon Nanotubes in Composites
- Plasma Diagnostics and Applications
- Cold Atom Physics and Bose-Einstein Condensates
- Mechanical and Optical Resonators
- Laser-induced spectroscopy and plasma
- Endometriosis Research and Treatment
Arkhangelsk State Technical University
2006-2007
Aim . To assess the efficacy and safety of lenvatinib pembrolizumab for treatment mismatch repair-proficient endometrial cancer (EC) in routine clinical practice Russia. Materials methods This multicenter, retrospective, cohort study included patients with recurrent metastatic EC from 37 centers Russia treated between May 2020 April 2023. Patients histologically verified without microsatellite instability who received ≥1 course pembrolizumab/lenvatinib therapy were study. The primary...
Background. Endometrial cancer (EC) treatment outcomes need to be improved. Immunotargeted therapy lead long-term and delayed effects compared chemotherapy. Estimation of efficacy quality life are crucial when we talking about in whole. Aim. To evaluate the clinical lenvatinib plus pembrolizumab patients with EC. Materials methods . The study included 43 stages I-IV EC mismatch repair-proficient tumors duration more than 9 months. We evaluated median progression-free survival, objective...